{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T17:52:53Z","timestamp":1767117173388},"reference-count":70,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"US Public Health Service National Institutes of Health","award":["NS50242"],"award-info":[{"award-number":["NS50242"]}]}],"content-domain":{"domain":["neurobiologyofaging.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.neurobiolaging.2014.10.014","type":"journal-article","created":{"date-parts":[[2014,10,15]],"date-time":"2014-10-15T22:47:37Z","timestamp":1413413257000},"page":"1174-1182","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Pharmacologic MRI (phMRI) as a tool to differentiate Parkinson's disease\u2013related from age-related changes in basal ganglia function"],"prefix":"10.1016","volume":"36","author":[{"given":"Anders H.","family":"Andersen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter A.","family":"Hardy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Forman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Greg A.","family":"Gerhardt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Don M.","family":"Gash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard C.","family":"Grondin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2014.10.014_bib1","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0165-0270(02)00273-X","article-title":"Automated segmentation of multispectral brain MR images","volume":"122","author":"Andersen","year":"2002","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.neurobiolaging.2014.10.014_bib2","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1749-6632.1993.tb23033.x","article-title":"Dopamine D2 receptors in normal human brain: effect of age measured by positron emission tomography (PET) and [11C]-raclopride","volume":"695","author":"Antonini","year":"1993","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neurobiolaging.2014.10.014_bib3","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1176\/appi.ajp.157.4.635","article-title":"Age-related cognitive deficits mediated by changes in the striatal dopamine system","volume":"157","author":"Backman","year":"2000","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2014.10.014_bib4","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.neubiorev.2009.12.008","article-title":"Linking cognitive aging to alterations in dopamine neurotransmitter functioning: recent data and future avenues","volume":"34","author":"Backman","year":"2010","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neurobiolaging.2014.10.014_bib5","doi-asserted-by":"crossref","first-page":"7095","DOI":"10.1073\/pnas.89.15.7095","article-title":"Dopamine transporter mRNA content in human substantia nigra decreases precipitously with age","volume":"89","author":"Bannon","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neurobiolaging.2014.10.014_bib6","doi-asserted-by":"crossref","first-page":"e45421","DOI":"10.1371\/journal.pone.0045421","article-title":"Globus Pallidus external segment neuron classification in freely moving rats: a comparison to primates","volume":"7","author":"Benhamou","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.neurobiolaging.2014.10.014_bib7","first-page":"71","article-title":"Prevalence of parkinsonian signs and associated mortality in a community population of older people. N. Engl","volume":"334","author":"Bennett","year":"1996","journal-title":"J. Med."},{"issue":"Pt 4","key":"10.1016\/j.neurobiolaging.2014.10.014_bib8","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1093\/brain\/117.4.859","article-title":"The behavioural and motor consequences of focal lesions of the basal ganglia in man","volume":"117","author":"Bhatia","year":"1994","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2014.10.014_bib9","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0014-2999(84)90238-3","article-title":"[3H]spiperone binding, dopamine and HVA concentrations in Parkinson's disease and supranuclear palsy","volume":"99","author":"Bokobza","year":"1984","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neurobiolaging.2014.10.014_bib10","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/ana.22588","article-title":"Nigral pathology and parkinsonian signs in elders without Parkinson disease","volume":"71","author":"Buchman","year":"2012","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2014.10.014_bib11","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0079-6123(08)00917-5","article-title":"Pharmacological inhibition of dopamine and serotonin activity blocks spontaneous and cocaine-activated behaviour","volume":"172","author":"Carey","year":"2008","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.neurobiolaging.2014.10.014_bib12","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.neurobiolaging.2005.12.010","article-title":"Iron accumulation in the striatum predicts aging-related decline in motor function in rhesus monkeys","volume":"28","author":"Cass","year":"2007","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2014.10.014_bib13","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.neuro.2005.10.006","article-title":"The diagnosis of manganese-induced parkinsonism","volume":"27","author":"Cersosimo","year":"2006","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neurobiolaging.2014.10.014_bib14","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/0730-725X(95)02100-8","article-title":"Mapping drug-induced changes in cerebral R2* by Multiple Gradient Recalled Echo functional MRI","volume":"14","author":"Chen","year":"1996","journal-title":"Magn. Reson. Imaging"},{"key":"10.1016\/j.neurobiolaging.2014.10.014_bib15","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s00213-004-2034-0","article-title":"Mapping dopamine D2\/D3 receptor function using pharmacological magnetic resonance imaging","volume":"180","author":"Chen","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neurobiolaging.2014.10.014_bib16","series-title":"The biochemical basis of neuropharmacology","author":"Cooper","year":"1996"},{"key":"10.1016\/j.neurobiolaging.2014.10.014_bib17","first-page":"426","article-title":"The aging striatal dopamine function. Parkinsonism Relat","volume":"18","author":"Darbin","year":"2012","journal-title":"Disord."},{"key":"10.1016\/j.neurobiolaging.2014.10.014_bib18","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1136\/jnnp.62.1.10","article-title":"Prevalence of parkinsonism and Parkinson's disease in Europe: the EUROPARKINSON Collaborative Study. European Community Concerted Action on the Epidemiology of Parkinson's disease","volume":"62","author":"de Rijk","year":"1997","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2014.10.014_bib19","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.expneurol.2008.04.027","article-title":"Development of a stable, early stage unilateral model of Parkinson's disease in middle-aged rhesus monkeys","volume":"212","author":"Ding","year":"2008","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neurobiolaging.2014.10.014_bib20","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/(SICI)1096-9861(19981116)401:2<253::AID-CNE7>3.0.CO;2-X","article-title":"Age-related declines in nigral neuronal function correlate with motor impairments in rhesus monkeys","volume":"401","author":"Emborg","year":"1998","journal-title":"J. Comp. Neurol."},{"issue":"Pt 5","key":"10.1016\/j.neurobiolaging.2014.10.014_bib21","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1093\/brain\/114.5.2283","article-title":"Ageing and Parkinson's disease: substantia nigra regional selectivity","volume":"114","author":"Fearnley","year":"1991","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2014.10.014_bib40","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/j.clinph.2008.03.017","article-title":"Pathophysiology of parkinsonism","volume":"119","author":"Galvan","year":"2008","journal-title":"Clin. Neurophysiol."},{"key":"10.1016\/j.neurobiolaging.2014.10.014_bib22","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/0197-4580(95)02013-6","article-title":"Age-related changes in potassium-evoked overflow of dopamine in the striatum of the rhesus monkey","volume":"16","author":"Gerhardt","year":"1995","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2014.10.014_bib23","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1046\/j.0022-3042.2001.00684.x","article-title":"Changes in somatodendritic but not terminal dopamine regulation in aged rhesus monkeys","volume":"80","author":"Gerhardt","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neurobiolaging.2014.10.014_bib24","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.neuroscience.2011.08.068","article-title":"Computational physiology of the neural networks of the primate globus pallidus: function and dysfunction","volume":"198","author":"Goldberg","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.neurobiolaging.2014.10.014_bib25","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1037\/a0027342","article-title":"Dopaminergic and prefrontal contributions to reward-based learning and outcome monitoring during child development and aging","volume":"48","author":"Hammerer","year":"2012","journal-title":"Dev. Psychol."},{"key":"10.1016\/j.neurobiolaging.2014.10.014_bib26","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/syn.10082","article-title":"Age-related changes in the striatal dopaminergic system in the living brain: a multiparametric PET study in conscious monkeys","volume":"45","author":"Harada","year":"2002","journal-title":"Synapse"},{"key":"10.1016\/j.neurobiolaging.2014.10.014_bib27","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/jmri.20244","article-title":"Correlation of R2 with total iron concentration in the brains of rhesus monkeys","volume":"21","author":"Hardy","year":"2005","journal-title":"J. Magn. Reson. Imaging"},{"key":"10.1016\/j.neurobiolaging.2014.10.014_bib28","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0006-8993(90)91813-V","article-title":"Evidence for interconnections between the two segments of the globus pallidus in primates: a PHA-L anterograde tracing study","volume":"533","author":"Hazrati","year":"1990","journal-title":"Brain Res."},{"key":"10.1016\/j.neurobiolaging.2014.10.014_bib29","first-page":"19","article-title":"Biochemical pathophysiology of Parkinson's disease","volume":"45","author":"Hornykiewicz","year":"1987","journal-title":"Adv. Neurol."},{"key":"10.1016\/j.neurobiolaging.2014.10.014_bib30","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1525-1403.2010.00318.x","article-title":"Comparison of contralateral pallidotomy vs. pallidal stimulation after prior unilateral pallidotomy for Parkinson's disease","volume":"14","author":"Hyam","year":"2011","journal-title":"Neuromodulation"},{"key":"10.1016\/j.neurobiolaging.2014.10.014_bib31","first-page":"251","article-title":"Aging and the nigrostriatal dopamine system: a non-human primate study","volume":"3","author":"Irwin","year":"1994","journal-title":"Neurodegeneration"},{"key":"10.1016\/j.neurobiolaging.2014.10.014_bib32","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/syn.20603","article-title":"Regional analysis of age-related decline in dopamine transporters and dopamine D2-like receptors in human striatum","volume":"63","author":"Ishibashi","year":"2009","journal-title":"Synapse"},{"key":"10.1016\/j.neurobiolaging.2014.10.014_bib33","doi-asserted-by":"crossref","first-page":"9553","DOI":"10.1523\/JNEUROSCI.1558-04.2004","article-title":"Mapping dopamine function in primates using pharmacologic magnetic resonance imaging","volume":"24","author":"Jenkins","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2014.10.014_bib34","first-page":"1845","article-title":"Pallidoreticular damage in acute carbon monoxide poisoning: diffusion-weighted MR imaging findings","volume":"26","author":"Kinoshita","year":"2005","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"10.1016\/j.neurobiolaging.2014.10.014_bib35","first-page":"876","article-title":"Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications. N. Engl","volume":"318","author":"Kish","year":"1988","journal-title":"J. Med."},{"key":"10.1016\/j.neurobiolaging.2014.10.014_bib36","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1001\/archneur.1992.00530310071014","article-title":"Local cerebral blood flow and its response to intravenous levodopa in progressive supranuclear palsy. Comparison with Parkinson's disease","volume":"49","author":"Kobari","year":"1992","journal-title":"Arch. Neurol."},{"issue":"Pt 3","key":"10.1016\/j.neurobiolaging.2014.10.014_bib37","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1093\/brain\/112.3.699","article-title":"Obsessive-compulsive and other behavioural changes with bilateral basal ganglia lesions. A neuropsychological, magnetic resonance imaging and positron tomography study","volume":"112","author":"Laplane","year":"1989","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2014.10.014_bib38","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0306-4522(96)00409-5","article-title":"Re-evaluation of the functional anatomy of the basal ganglia in normal and Parkinsonian states","volume":"76","author":"Levy","year":"1997","journal-title":"Neuroscience"},{"key":"10.1016\/j.neurobiolaging.2014.10.014_bib39","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1002\/mds.21433","article-title":"Mild Parkinsonian signs: An overview of an emerging concept","volume":"22","author":"Louis","year":"2007","journal-title":"Mov Disord."},{"key":"10.1016\/j.neurobiolaging.2014.10.014_bib41","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1159\/000314495","article-title":"Significance of MRI in diagnosis and differential diagnosis of Parkinson's disease","volume":"7","author":"Mahlknecht","year":"2010","journal-title":"Neurodegener Dis."},{"key":"10.1016\/j.neurobiolaging.2014.10.014_bib42","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0304-3940(94)90462-6","article-title":"Iron accumulation in the substantia nigra of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced hemiparkinsonian monkeys","volume":"168","author":"Mochizuki","year":"1994","journal-title":"Neurosci. Lett."},{"issue":"Suppl 2","key":"10.1016\/j.neurobiolaging.2014.10.014_bib43","first-page":"S30","article-title":"The basal ganglia in Parkinson's disease: current concepts and unexplained observations","volume":"64","author":"Obeso","year":"2008","journal-title":"Ann. Neurol."},{"issue":"Suppl 3","key":"10.1016\/j.neurobiolaging.2014.10.014_bib44","doi-asserted-by":"crossref","first-page":"S548","DOI":"10.1002\/mds.22062","article-title":"Functional organization of the basal ganglia: therapeutic implications for Parkinson's disease","volume":"23","author":"Obeso","year":"2008","journal-title":"Mov Disord."},{"key":"10.1016\/j.neurobiolaging.2014.10.014_bib45","first-page":"125","article-title":"Surgical treatment of Parkinson's disease. Baillieres Clin","volume":"6","author":"Obeso","year":"1997","journal-title":"Neurol."},{"key":"10.1016\/j.neurobiolaging.2014.10.014_bib46","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1212\/WNL.46.2.492","article-title":"Manganese intoxication in the rhesus monkey: a clinical, imaging, pathologic, and biochemical study","volume":"46","author":"Olanow","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2014.10.014_bib47","first-page":"45","article-title":"Extrastriatal dopamine and Parkinson's disease","volume":"86","author":"Parent","year":"2001","journal-title":"Adv. Neurol."},{"key":"10.1016\/j.neurobiolaging.2014.10.014_bib48","first-page":"128","article-title":"Functional anatomy of the basal ganglia. II. The place of subthalamic nucleus and external pallidum in basal ganglia circuitry. Brain Res. Brain Res","volume":"20","author":"Parent","year":"1995","journal-title":"Rev."},{"key":"10.1016\/j.neurobiolaging.2014.10.014_bib49","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/sj.mp.4000350","article-title":"The A1 allele of the human D2 dopamine receptor gene predicts low D2 receptor availability in healthy volunteers","volume":"3","author":"Pohjalainen","year":"1998","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2014.10.014_bib50","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0891-0618(00)00099-5","article-title":"Dopaminergic innervation of human basal ganglia","volume":"20","author":"Prensa","year":"2000","journal-title":"J. Chem. Neuroanat."},{"key":"10.1016\/j.neurobiolaging.2014.10.014_bib51","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1002\/jnr.490270409","article-title":"PET demonstrates different behaviour of striatal dopamine D-1 and D-2 receptors in early Parkinson's disease","volume":"27","author":"Rinne","year":"1990","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.neurobiolaging.2014.10.014_bib52","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/mds.870080203","article-title":"PET study on striatal dopamine D2 receptor changes during the progression of early Parkinson's disease","volume":"8","author":"Rinne","year":"1993","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neurobiolaging.2014.10.014_bib53","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/(SICI)1096-9861(20000131)417:1<17::AID-CNE2>3.0.CO;2-I","article-title":"Single-axon tracing study of neurons of the external segment of the globus pallidus in primate","volume":"417","author":"Sato","year":"2000","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neurobiolaging.2014.10.014_bib54","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1007\/s00259-004-1465-5","article-title":"The dopamine D2 receptor ligand 18F-desmethoxyfallypride: an appropriate fluorinated PET tracer for the differential diagnosis of parkinsonism","volume":"31","author":"Schreckenberger","year":"2004","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.neurobiolaging.2014.10.014_bib55","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1006\/brcg.1995.1259","article-title":"The use of PET in Parkinson's disease","volume":"28","author":"Shinotoh","year":"1995","journal-title":"Brain Cogn."},{"key":"10.1016\/j.neurobiolaging.2014.10.014_bib56","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1007\/s00259-009-1357-9","article-title":"Recent advances in PET imaging for evaluation of Parkinson's disease","volume":"37","author":"Sioka","year":"2010","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.neurobiolaging.2014.10.014_bib57","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1212\/WNL.53.7.1458","article-title":"Critical decline in fine motor hand movements in human aging","volume":"53","author":"Smith","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2014.10.014_bib58","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1460-9568.2007.05990.x","article-title":"Motor cortical control of internal pallidal activity through glutamatergic and GABAergic inputs in awake monkeys","volume":"27","author":"Tachibana","year":"2008","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2014.10.014_bib59","first-page":"1325","article-title":"Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate. Am","volume":"155","author":"Volkow","year":"1998","journal-title":"J. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2014.10.014_bib60","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1176\/ajp.155.10.1325","article-title":"Measuring age-related changes in dopamine D2 receptors with 11C-raclopride and 18F-N-methylspiroperidol","volume":"67","author":"Volkow","year":"1996","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.neurobiolaging.2014.10.014_bib61","doi-asserted-by":"crossref","first-page":"PL249","DOI":"10.1016\/0024-3205(95)00066-F","article-title":"Evaluation of age-related changes in serotonin 5-HT2 and dopamine D2 receptor availability in healthy human subjects","volume":"56","author":"Wang","year":"1995","journal-title":"Life Sci."},{"key":"10.1016\/j.neurobiolaging.2014.10.014_bib62","series-title":"Aging and Human Skill","author":"Welford","year":"1958"},{"key":"10.1016\/j.neurobiolaging.2014.10.014_bib63","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1016\/j.neurobiolaging.2007.03.022","article-title":"An MRI study of age-related white and gray matter volume changes in the rhesus monkey","volume":"29","author":"Wisco","year":"2008","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2014.10.014_bib64","first-page":"1243","article-title":"D2-like dopamine receptor density in Tourette syndrome measured by PET","volume":"38","author":"Wong","year":"1997","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.neurobiolaging.2014.10.014_bib65","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1080\/713803493","article-title":"The role of iron in Parkinson disease and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity","volume":"48","author":"Yantiri","year":"1999","journal-title":"IUBMB Life"},{"key":"10.1016\/j.neurobiolaging.2014.10.014_bib66","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/0306-4522(96)00047-4","article-title":"Interaction of neuromelanin and iron in substantia nigra and other areas of human brain","volume":"73","author":"Zecca","year":"1996","journal-title":"Neuroscience"},{"key":"10.1016\/j.neurobiolaging.2014.10.014_bib67","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1006\/nimg.2001.0902","article-title":"Pharmacological MRI mapping of age-associated changes in basal ganglia circuitry of awake rhesus monkeys","volume":"14","author":"Zhang","year":"2001","journal-title":"Neuroimage"},{"key":"10.1016\/j.neurobiolaging.2014.10.014_bib68","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.neuroimage.2006.07.004","article-title":"Assessing nigrostriatal dysfunctions by pharmacological MRI in parkinsonian rhesus macaques","volume":"33","author":"Zhang","year":"2006","journal-title":"Neuroimage"},{"key":"10.1016\/j.neurobiolaging.2014.10.014_bib69","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S0006-8993(99)02243-X","article-title":"Functional MRI of apomorphine activation of the basal ganglia in awake rhesus monkeys","volume":"852","author":"Zhang","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.neurobiolaging.2014.10.014_bib70","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1006\/exnr.1998.6976","article-title":"MPTP-Induced pallidal lesions in rhesus monkeys","volume":"155","author":"Zhang","year":"1999","journal-title":"Exp. Neurol."}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019745801400671X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019745801400671X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,28]],"date-time":"2018-09-28T09:28:03Z","timestamp":1538126883000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S019745801400671X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":70,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S019745801400671X"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2014.10.014","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacologic MRI (phMRI) as a tool to differentiate Parkinson's disease\u2013related from age-related changes in basal ganglia function","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2014.10.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}